Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Creative exploration as a scale-invariant search on a meaning landscape.

Hart Y, Goldberg H, Striem-Amit E, Mayo AE, Noy L, Alon U.

Nat Commun. 2018 Dec 21;9(1):5411. doi: 10.1038/s41467-018-.

2.

The Body Speaks: Using the Mirror Game to Link Attachment and Non-verbal Behavior.

Feniger-Schaal R, Hart Y, Lotan N, Koren-Karie N, Noy L.

Front Psychol. 2018 Aug 23;9:1560. doi: 10.3389/fpsyg.2018.01560. eCollection 2018.

3.

The statistical shape of geometric reasoning.

Hart Y, Dillon MR, Marantan A, Cardenas AL, Spelke E, Mahadevan L.

Sci Rep. 2018 Aug 27;8(1):12906. doi: 10.1038/s41598-018-30314-y.

4.

The more the merrier? Increasing group size may be detrimental to decision-making performance in nominal groups.

Amir O, Amir D, Shahar Y, Hart Y, Gal K.

PLoS One. 2018 Feb 27;13(2):e0192213. doi: 10.1371/journal.pone.0192213. eCollection 2018.

5.

Placebo can enhance creativity.

Rozenkrantz L, Mayo AE, Ilan T, Hart Y, Noy L, Alon U.

PLoS One. 2017 Sep 11;12(9):e0182466. doi: 10.1371/journal.pone.0182466. eCollection 2017.

6.

Creative foraging: An experimental paradigm for studying exploration and discovery.

Hart Y, Mayo AE, Mayo R, Rozenkrantz L, Tendler A, Alon U, Noy L.

PLoS One. 2017 Aug 2;12(8):e0182133. doi: 10.1371/journal.pone.0182133. eCollection 2017.

7.

A Woman With Intellectual Disability, Amenorrhoea, Seizures, and Balance Problems.

Hughes AJ, Steele HE, Pyle A, Hart Y, Quinton R, Chinnery PF.

JAMA Neurol. 2016 Dec 1;73(12):1494-1495. doi: 10.1001/jamaneurol.2016.3613. No abstract available.

8.

Exit from Synchrony in Joint Improvised Motion.

Dahan A, Noy L, Hart Y, Mayo A, Alon U.

PLoS One. 2016 Oct 6;11(10):e0160747. doi: 10.1371/journal.pone.0160747. eCollection 2016.

9.

Automated Video Analysis of Non-verbal Communication in a Medical Setting.

Hart Y, Czerniak E, Karnieli-Miller O, Mayo AE, Ziv A, Biegon A, Citron A, Alon U.

Front Psychol. 2016 Aug 23;7:1130. doi: 10.3389/fpsyg.2016.01130. eCollection 2016.

10.

Safe use of perampanel in a carrier of variegate porphyria.

Balestrini S, Hart Y, Thunell S, Sisodiya SM.

Pract Neurol. 2016 Jun;16(3):217-9. doi: 10.1136/practneurol-2015-001305. Epub 2016 Feb 2. No abstract available.

PMID:
26837372
11.

Would you like to play together? Adults' attachment and the mirror game.

Feniger-Schaal R, Noy L, Hart Y, Koren-Karie N, Mayo AE, Alon U.

Attach Hum Dev. 2016;18(1):33-45. doi: 10.1080/14616734.2015.1109677. Epub 2015 Nov 25.

PMID:
26608053
12.

Geometry of the Gene Expression Space of Individual Cells.

Korem Y, Szekely P, Hart Y, Sheftel H, Hausser J, Mayo A, Rothenberg ME, Kalisky T, Alon U.

PLoS Comput Biol. 2015 Jul 10;11(7):e1004224. doi: 10.1371/journal.pcbi.1004224. eCollection 2015 Jul.

13.

Inferring biological tasks using Pareto analysis of high-dimensional data.

Hart Y, Sheftel H, Hausser J, Szekely P, Ben-Moshe NB, Korem Y, Tendler A, Mayo AE, Alon U.

Nat Methods. 2015 Mar;12(3):233-5, 3 p following 235. doi: 10.1038/nmeth.3254. Epub 2015 Jan 26.

PMID:
25622107
14.

Paradoxical signaling by a secreted molecule leads to homeostasis of cell levels.

Hart Y, Reich-Zeliger S, Antebi YE, Zaretsky I, Mayo AE, Alon U, Friedman N.

Cell. 2014 Aug 28;158(5):1022-1032. doi: 10.1016/j.cell.2014.07.033.

15.

Rasmussen encephalitis and comorbid autoimmune diseases: A window into disease mechanism?

Amrom D, Kinay D, Hart Y, Berkovic SF, Laxer K, Andermann F, Andermann E, Bar-Or A.

Neurology. 2014 Sep 16;83(12):1049-55. doi: 10.1212/WNL.0000000000000791. Epub 2014 Aug 20.

16.

Individuality and togetherness in joint improvised motion.

Hart Y, Noy L, Feniger-Schaal R, Mayo AE, Alon U.

PLoS One. 2014 Feb 12;9(2):e87213. doi: 10.1371/journal.pone.0087213. eCollection 2014.

17.

Response to comment on "Evolutionary trade-offs, Pareto optimality, and the geometry of phenotype space".

Shoval O, Sheftel H, Shinar G, Hart Y, Ramote O, Mayo A, Dekel E, Kavanagh K, Alon U.

Science. 2013 Feb 15;339(6121):757. doi: 10.1126/science.1228921.

PMID:
23413339
18.

Mapping differentiation under mixed culture conditions reveals a tunable continuum of T cell fates.

Antebi YE, Reich-Zeliger S, Hart Y, Mayo A, Eizenberg I, Rimer J, Putheti P, Pe'er D, Friedman N.

PLoS Biol. 2013 Jul;11(7):e1001616. doi: 10.1371/journal.pbio.1001616. Epub 2013 Jul 30.

19.

The last generation of bacterial growth in limiting nutrient.

Bren A, Hart Y, Dekel E, Koster D, Alon U.

BMC Syst Biol. 2013 Mar 25;7:27. doi: 10.1186/1752-0509-7-27.

20.

Comparing apples and oranges: fold-change detection of multiple simultaneous inputs.

Hart Y, Mayo AE, Shoval O, Alon U.

PLoS One. 2013;8(3):e57455. doi: 10.1371/journal.pone.0057455. Epub 2013 Mar 4.

21.

Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy.

Brenner T, Sills GJ, Hart Y, Howell S, Waters P, Brodie MJ, Vincent A, Lang B.

Epilepsia. 2013 Jun;54(6):1028-35. doi: 10.1111/epi.12127. Epub 2013 Mar 6.

22.

The utility of paradoxical components in biological circuits.

Hart Y, Alon U.

Mol Cell. 2013 Jan 24;49(2):213-21. doi: 10.1016/j.molcel.2013.01.004. Review.

23.

All that shakes is not epilepsy.

Hart YM.

J R Coll Physicians Edinb. 2012 Jun;42(2):151-4. doi: 10.4997/JRCPE.2012.213. Review.

PMID:
22693702
24.

Design principles of cell circuits with paradoxical components.

Hart Y, Antebi YE, Mayo AE, Friedman N, Alon U.

Proc Natl Acad Sci U S A. 2012 May 22;109(21):8346-51. doi: 10.1073/pnas.1117475109. Epub 2012 May 4.

25.

Evolutionary trade-offs, Pareto optimality, and the geometry of phenotype space.

Shoval O, Sheftel H, Shinar G, Hart Y, Ramote O, Mayo A, Dekel E, Kavanagh K, Alon U.

Science. 2012 Jun 1;336(6085):1157-60. doi: 10.1126/science.1217405. Epub 2012 Apr 26.

26.

Robust control of PEP formation rate in the carbon fixation pathway of C(4) plants by a bi-functional enzyme.

Hart Y, Mayo AE, Milo R, Alon U.

BMC Syst Biol. 2011 Oct 24;5:171. doi: 10.1186/1752-0509-5-171.

27.

An siRNA screen identifies transmembrane 7 superfamily member 3 (TM7SF3), a seven transmembrane orphan receptor, as an inhibitor of cytokine-induced death of pancreatic beta cells.

Beck A, Isaac R, Lavelin I, Hart Y, Volberg T, Shatz-Azoulay H, Geiger B, Zick Y.

Diabetologia. 2011 Nov;54(11):2845-55. doi: 10.1007/s00125-011-2277-3. Epub 2011 Aug 19.

PMID:
21853325
28.

Epilepsy after subarachnoid hemorrhage: the frequency of seizures after clip occlusion or coil embolization of a ruptured cerebral aneurysm: results from the International Subarachnoid Aneurysm Trial.

Hart Y, Sneade M, Birks J, Rischmiller J, Kerr R, Molyneux A.

J Neurosurg. 2011 Dec;115(6):1159-68. doi: 10.3171/2011.6.JNS101836. Epub 2011 Aug 5.

PMID:
21819189
29.

Epilepsy and the subsequent risk of cerebral tumour: record linkage retrospective cohort study.

Khan T, Akhtar W, Wotton CJ, Hart Y, Turner MR, Goldacre MJ.

J Neurol Neurosurg Psychiatry. 2011 Sep;82(9):1041-5. doi: 10.1136/jnnp.2010.228130. Epub 2011 Mar 28.

PMID:
21444323
30.

Lumpy breasts and headache--a crucial ultrasound.

Hinze S, Hart YM, Adams RF.

Br J Radiol. 2011 Apr;84(1000):386-7. doi: 10.1259/bjr/23418860. No abstract available.

31.

Robust control of nitrogen assimilation by a bifunctional enzyme in E. coli.

Hart Y, Madar D, Yuan J, Bren A, Mayo AE, Rabinowitz JD, Alon U.

Mol Cell. 2011 Jan 7;41(1):117-27. doi: 10.1016/j.molcel.2010.12.023.

32.

Fold-change detection and scalar symmetry of sensory input fields.

Shoval O, Goentoro L, Hart Y, Mayo A, Sontag E, Alon U.

Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15995-6000. doi: 10.1073/pnas.1002352107. Epub 2010 Aug 20.

33.

Functional and structural changes in the memory network associated with left temporal lobe epilepsy.

Voets NL, Adcock JE, Stacey R, Hart Y, Carpenter K, Matthews PM, Beckmann CF.

Hum Brain Mapp. 2009 Dec;30(12):4070-81. doi: 10.1002/hbm.20830.

PMID:
19517529
34.

Transcallosal resection of hypothalamic hamartoma for gelastic epilepsy.

Andrew M, Parr JR, Stacey R, Rosenfeld JV, Hart Y, Pretorius P, Nijhawan S, Zaiwalla Z, McShane MA.

Childs Nerv Syst. 2008 Feb;24(2):275-9. Epub 2007 Sep 9.

PMID:
17828541
35.

Audit of resource use in patients with non-organic disorders admitted to a UK neurology unit.

Parry AM, Murray B, Hart Y, Bass C.

J Neurol Neurosurg Psychiatry. 2006 Oct;77(10):1200-1. Epub 2006 Apr 25. No abstract available.

36.

Alpha7-acetylcholine receptor antibodies in two patients with Rasmussen encephalitis.

Watson R, Jepson JE, Bermudez I, Alexander S, Hart Y, McKnight K, Roubertie A, Fecto F, Valmier J, Sattelle DB, Beeson D, Vincent A, Lang B.

Neurology. 2005 Dec 13;65(11):1802-4.

PMID:
16344526
37.

Serum antibodies in epilepsy and seizure-associated disorders.

McKnight K, Jiang Y, Hart Y, Cavey A, Wroe S, Blank M, Shoenfeld Y, Vincent A, Palace J, Lang B.

Neurology. 2005 Dec 13;65(11):1730-6.

PMID:
16344514
38.

Distinct right frontal lobe activation in language processing following left hemisphere injury.

Voets NL, Adcock JE, Flitney DE, Behrens TE, Hart Y, Stacey R, Carpenter K, Matthews PM.

Brain. 2006 Mar;129(Pt 3):754-66. Epub 2005 Nov 9.

PMID:
16280351
39.

Rasmussen's encephalitis.

Hart Y.

Epileptic Disord. 2004 Sep;6(3):133-44. Review.

40.

Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.

Watson R, Jiang Y, Bermudez I, Houlihan L, Clover L, McKnight K, Cross JH, Hart IK, Roubertie A, Valmier J, Hart Y, Palace J, Beeson D, Vincent A, Lang B.

Neurology. 2004 Jul 13;63(1):43-50.

PMID:
15249609
41.

Levetiracetam: an innovative and cost-effective add-on drug for refractory partial epilepsy.

Lorier JL, Godfroid P, Hart Y, Roberts R.

Expert Rev Pharmacoecon Outcomes Res. 2004 Apr;4(2):143-51. doi: 10.1586/14737167.4.2.143.

PMID:
19807517
42.

What's a new safety manager to do?

Hart YW.

Occup Health Saf. 2003 Jun;72(6):20-2, 24. No abstract available.

PMID:
12813933
43.

When can antiepileptic drugs be safely withdrawn?

Hart Y.

J Neurol Neurosurg Psychiatry. 2002 Jan;72(1):5. No abstract available.

44.

Rasmussen's syndrome, with particular reference to cerebral plasticity: a tribute to Frank Morrell.

Andermann F, Hart Y.

Int Rev Neurobiol. 2001;45:173-208. Review. No abstract available.

PMID:
11130899
45.

Neurology and medicine

Hart Y.

BMJ. 2000 May 6;320(7244):1281. No abstract available.

46.

Migraine aura, seizures, and temporal lobe epilepsy.

Hart YM, Andermann F.

Adv Neurol. 1999;81:145-52. Review. No abstract available.

PMID:
10609011
47.

Sarcoidosis presenting as palmar erythema.

Cliff S, Hart Y, Knowles G, Misch K.

Clin Exp Dermatol. 1998 May;23(3):123-4.

PMID:
9861742
48.

Amyloid angiopathy causing widespread miliary haemorrhages within the brain evident on MRI.

Good CD, Ng VW, Clifton A, Britton JA, Hart Y, Wilkins P.

Neuroradiology. 1998 May;40(5):308-11.

PMID:
9638672
49.

Anti-epileptic drug treatment in rural Africa: involving the community.

Hart Y.

Trop Doct. 1998 Apr;28(2):66. No abstract available.

PMID:
9594668
50.

Double pathology in Rasmussen's syndrome: a window on the etiology?

Hart YM, Andermann F, Robitaille Y, Laxer KD, Rasmussen T, Davis R.

Neurology. 1998 Mar;50(3):731-5.

PMID:
9521265

Supplemental Content

Support Center